X, L., Y, J., B, L., Z, Y., & R, X. (2026). SMARCA4-deficient non-small cell lung cancer and immunotherapy resistance: Mechanisms and novel strategies-a mini-review. Discover oncology, 17(1), . https://doi.org/10.1007/s12672-026-04768-w
Chicago Style (17th ed.) CitationX, Lin, Ji Y, Lin B, Yang Z, and Xie R. "SMARCA4-deficient Non-small Cell Lung Cancer and Immunotherapy Resistance: Mechanisms and Novel Strategies-a Mini-review." Discover Oncology 17, no. 1 (2026). https://doi.org/10.1007/s12672-026-04768-w.
MLA (9th ed.) CitationX, Lin, et al. "SMARCA4-deficient Non-small Cell Lung Cancer and Immunotherapy Resistance: Mechanisms and Novel Strategies-a Mini-review." Discover Oncology, vol. 17, no. 1, 2026, https://doi.org/10.1007/s12672-026-04768-w.